Skip to main content
Equibles

Velan Capital Investment Management LP

Position in EDSA — Edesa Biotech, Inc.

CIK 1848809 ALPHARETTA, GA
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,727,575
+$2,399,750 QoQ
Shares Held
827,500
0.0% QoQ
Ownership
8.58%
of shares outstanding
% of Portfolio
4.12%
of 13F equity value
Holder Rank
#1
of 33 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. EDSA ranks #8 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 88,781 $29,722,990
2 MPLT
MapLight Therapeutics, Inc.
 492,893 $17,665,285
3 STRO
Sutro Biopharma, Inc.
 512,160 $17,003,712
4 IMMX
Immix Biopharma, Inc.
 1,085,000 $11,186,350
5 TARA
Protara Therapeutics, Inc.
 2,844,652 $10,866,570
6 ABVX
Abivax S.A.
 65,630 $8,745,853
7 TENX
Tenax Therapeutics, Inc.
 549,985 $8,002,281
8 EDSA
Edesa Biotech, Inc.
This page 		827,500 $6,727,575

All Filings in EDSA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,727,575 827,500
2026-03-31 $4,327,825 827,500
2025-12-31 $976,250 687,500
2025-09-30 $1,698,125 687,500
2025-06-30 $1,395,625 687,500
2025-03-31 $1,677,500 687,500
2023-09-30 $807,417 1,281,615
2023-06-30 $1,038,108 1,281,615
2023-03-31 $1,166,269 1,281,615
2022-12-31 $1,919,998 888,888